Sands Capital Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 72

Professionals

  • Investments
  • 188

  • Portfolio
  • 69

  • Exits
  • 55

Exits

Sands Capital General Information

Company Description

Founded in 1992, Sands Capital is a growth equity firm based in Arlington, Virginia. The firm prefers to invest in companies operating in healthcare, business products and services, consumer products and services, artificial intelligence, machine learning, cybersecurity, healthcare technology, digital life, and technology sectors. The firm has additional offices in London and Singapore.

Business Details

Year Founded
1992
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Growth/Expansion
Other Investor Types
Asset Manager
Corporate Venture Capital
Mutual Fund
Venture Capital
Corporate Office
  • 1000 Wilson Boulevard
  • Suite 3000
  • Arlington, VA 22209
  • United States
+1 (703) 000-0000

Sands Capital Investments (188)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Acrivon Therapeutics 09-Apr-2024 0000 00000 Drug Discovery Generating Revenue
SeLux Dx 01-Apr-2024 00000 00000 0000 Biotechnology Generating Revenue 000000 0000000
Avenzo 27-Mar-2024 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
Alamar Biosciences 26-Feb-2024 00000 00000 00000 Diagnostic Equipment Generating Revenue 000 000000000
HealthSnap 21-Feb-2024 Later Stage VC 0000 Outcome Management (Healthcare) Generating Revenue 00000 000000000 00
You’re viewing 5 of 188 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sands Capital Exits (55)

Company Name Exit Date Exit Type Exit Size
Betable 01-Feb-2024 000000000 00000000
ModMed 01-Feb-2024 000000000 00000000
WireWheel 04-Dec-2023 000000000000000000
Klaviyo 19-Sep-2023 000 00000
RayzeBio 15-Sep-2023 IPO 00000
You’re viewing 5 of 55 exits. Get the full list »

Sands Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sands Capital Management, Team & Partners (96)

Name Title Deals Funds Boards Office
Frank Sands Jr. Chief Investment Officer & Chief Executive Officer 0 0 Arlington, VA
T. Perry Williams President & Director of Research Arlington, VA
Ryan Bateman Chief Technology Officer & Chief Information Security Officer Arlington, VA
Ian Ratcliffe Executive Managing Partner & Executive Managing Director 00 0 0 Arlington, VA
Dana McNamara Executive Managing Director & Chief Administrative Officer Arlington, VA
You’re viewing 5 of 96 team members. Get the full list »

Sands Capital FAQs

  • What is Sands Capital?

    Founded in 1992, Sands Capital is a growth equity firm based in Arlington, Virginia.

  • When was Sands Capital founded?

    Sands Capital was founded in 1992.

  • Who is the founder of Sands Capital?

    Christopher Eng and Michael Rubin MD are the founders of Sands Capital.

  • Who is the CEO of Sands Capital?

    Frank Sands Jr. is the CEO of Sands Capital.

  • Where is Sands Capital headquartered?

    Sands Capital is headquartered in Arlington, VA.

  • What is Sands Capital's total asset value?

    Sands Capital has around 00.00 in total assets under management.

  • How many investments has Sands Capital made?

    Sands Capital has made 188 investments.

  • What has Sands Capital invested in?

    Sands Capital has made numerous investments in companies like Acrivon Therapeutics, SeLux Dx, and Avenzo within the Drug Discovery and Biotechnology industries.

  • What has Sands Capital invested in recently?

    Sands Capital's latest investment was on 09-Apr-2024 in Acrivon Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »